期刊文献+

A型肉毒毒素治疗半面痉挛及眼睑痉挛 被引量:9

Blepharospasm and hemifacial spasm treated with botulinum A toxin injection
暂未订购
导出
摘要 目的观察A型肉毒毒素治疗半面痉挛及眼睑痉挛的效果。方法A型肉毒毒素局部注射(每点2.5~5U)治疗眼睑痉挛12例(15侧)及半面痉挛38例。结果完全缓解分别为10例(13侧,占86.7%)及32例(84.2%),明显缓解分别为2例(13.3%)及5例(13.2%),部分缓解分别为0例及1例(2.6%)。总有效率100%。药效作用时间分别为10~24周(平均18周)及14~32周(平均22周)。局部副反应轻微、短暂,包括轻度面瘫8例、眼睑下垂4例、流泪4例,无全身反应及过敏反应。结论A型肉毒毒素局部注射是治疗眼睑痉挛及半面痉挛的一种安全、有效、简便方法。 Objective To study the efficacy of botulinum A toxin (BTA) injections for the treatment of blepharospasm and hemifacial spasm (HFS). Methods Twelve patients with blepharospasm and thirty eight patients with HFS were treated with BTA local injections (2.5U to 5U for each injection). Results Of the fifty patients, ten (86.7%) in blepharospasm and thirty two (84.2%) in HFS were completely relieved, two (13.3%) and five (13.2%) were remarkably relieved respectively, zero and one (2.6%) were partial relieved respectively. All patients experienced relief from spasm. The duration of the effect in blepharospasm were 10 to 24 weeks (mean, 18 weeks) and in HFS 14 to 32 weeks (mean, 22 weeks). The local side effects were transient and mild, including minor facial paralysis in eight patients, ptosis in four patients and tearing in four patients. No systemic adverse and allergic reactions were noted. Conclusion Botulinum A toxin local injection is a safe, effective and simple means for the treatment of blepharospasm and HFS.
出处 《中华耳鼻咽喉科杂志》 CSCD 1998年第5期291-293,共3页 Chinese Journal of Otorhinolaryngology
关键词 肉毒毒素 眼睑痉挛 半面痉挛 Botulinum toxin Blepharospasm Facial nerve diseases Muscle spasticity
  • 相关文献

参考文献1

  • 1戴壮,中华眼科杂志,1993年,29卷,144页

同被引文献29

  • 1韩杰,王海波,樊兆民,樊忠.面肌痉挛的病因及手术治疗的探讨[J].临床耳鼻咽喉科杂志,2004,18(7):404-405. 被引量:14
  • 2戴壮,卢炜.A型肉毒杆菌毒素治疗眼睑及面肌痉挛的临床研究[J].中华眼科杂志,1993,29(3):144-145. 被引量:54
  • 3刘增玉,于秀浚,张晓.A型肉毒杆菌毒素治疗睑痉挛的病理与临床研究[J].中国实用眼科杂志,1996,14(3):172-175. 被引量:19
  • 4Hughes AJ,Botulinum toxin in clinical practice.Drugs,1994,48:888-893.
  • 5Barker F G, Jannetta P J, Bissonette D J, et al. Microvascular decompression for hemifacial spasm. J Neurosurg, 1995, 82:201-210.
  • 6Dressler D.Clinical presentation and management of antibody-induced failure of botulinum toxin therapy.Mov Disord,2004,Suppl 8:S92-S100.
  • 7Dressler D.Antibody-induced failure of botulinum toxin therapy.Nervenarzt,2003,74:1098-1104.
  • 8Voller B,Moraru E,Auff E,et al.Ninhydrin sweat test:a simple method for detecting antibodies neutralizing botulinum toxin type A.Mov Disord,2004,19:943-947.
  • 9Calace P,Cortese G,Piscopo R,et al.Treatment of blepharospasm with botulinum neurotoxin type A:long-term results.Eur J Ophthalmol,2003,13:331-336.
  • 10Taylor J D,Kraft S P,Kazdan M S,et al.Treatment of blepharospasm and hemifacial spasm with botulinum A toxin:a Canadian multicentre study.Can J Ophthalmol,1991,26:133-138.

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部